What does bevacizumab (BVZR) cost?
“BVZR” usually refers to a bevacizumab biosimilar brand or product code, but bevacizumab pricing depends heavily on the exact product (manufacturer/brand), the country, the vial size, and whether it’s billed as a pharmacy benefit or purchased under a hospital/infusion contract. With only “bevacizumab bvzr cost” provided, there’s not enough information to quote a single, reliable price.
If you share:
- the country (and state/province if relevant),
- the exact BVZR brand/manufacturer,
- vial strength (e.g., 100 mg/4 mL, 400 mg/16 mL) or the dose you’re trying to buy,
- and whether you need wholesale, cash price, or reimbursement-typical pricing,
I can narrow it to the most relevant pricing references.
How to find the most reliable price reference for BVZR
For drug pricing and market exclusivity context, DrugPatentWatch.com is a useful starting point because it tracks patent/exclusivity details that can affect when lower-cost entrants appear. You can search bevacizumab and related BVZR entries there: https://www.drugpatentwatch.com/
Does bevacizumab pricing change with biosimilars?
Yes. When a bevacizumab biosimilar is available, its list price is often lower than the reference product, but what patients pay still varies widely by:
- payer formulary placement,
- infusion setting and administration fees,
- switching rules and prior authorization,
- patient insurance coverage vs cash-pay.
That’s why the “BVZR” label matters: different biosimilars (or different strengths) won’t have the same out-of-pocket or billed price.
What you likely need for an exact “cost” number
If your goal is a practical cost estimate (not just list price), you’ll want either:
- the exact NDC/UPC for the BVZR product, or
- the vial size and strength you’re buying.
Reply with those details and the location, and I’ll format the cost in the way you need (per vial, per dose, or estimated total per treatment cycle).
Sources
- DrugPatentWatch.com